PRMT5 TR-FRET Assay Kit

Catalog #
52171
$1,350 *
Size: 384 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The PRMT5 TR-FRET Assay Kit is designed to measure PRMT5 activity in a homogeneous 384 reaction format. PRMT5 is a histone methyltransferase that exhibits methylation activity toward H4-R3. This FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The key to the PRMT5 TR-FRET Assay Kit is a highly specific antibody that recognizes methylated substrate.

Need us to run inhibitor screens or profile your compounds against PRMT5? Check out our Methyltransferase Screening Services or DNA Replication & Repair Screening Services

Synonyms
PRMT5, HRMT1L5, IBP72, JBP1, SKB1, HTRF, PRMT-5
Product Info
Storage and Usage
Citations
Assay Kit Format
TR-FRET
Supplied As
The PRMT5 TR-FRET Assay Kit comes in a convenient format, with histone H4 peptide substrate, a Eu-labeled antibody, S-adenosylmethionine, methyltransferase assay buffer, FRET detection buffer, dye-labeled acceptor, and purified PRMT5.
Format
Catalog # Component Amount Storage 
51045 PRMT5/MEP50* 40 µg -80°C Avoid
freeze/
thaw
cycles!
52120 60 µM S-adenosylmethionine 250 µl -80°C
  Eu-labeled antibody 5 µl -80°C
  Biotinylated histone H4 peptide substrate 1000 rxns -80°C
  4x PRMT5 assay buffer** 3 x 1 ml -20°C
  Dye-labeled acceptor 2 x 10 µl -20°C
78314 PRMT5 TR-FRET Detection Buffer 4 ml -20°C
79969 White, nonbinding, low volume, microtiter plate 1 Room Temp.
 

 

 


 

 

 

 

 

 

 

 

 

*The concentration of PRMT5 is lot-specific and will be indicated on the tube containing the enzyme.
**Add 10 µl of 0.5 M DTT per vial before use.

Background

PRMT5 is a histone methyltransferase that exhibits methylation activity toward H4-R3. PRMT5 is a critical regulatory-protein linked to genome organization, cell cycle regulation, and stem cell differentiation. PRMT5 transfers methyl groups from S-adenosylmethoinine (SAM) to form mono and symmetric di-methylated arginine residues in histone proteins, transcription factors, and other regulatory proteins. Given its regulatory function, PRMT5 is believed to contribute to tumorigenesis. Its dysregulated activity has been associated with many cancers including lymphomas, lung, and breast cancer. Additionally, PRMT5 has been linked to other diseases including kidney and heart disease as well as neurological disorders such as Huntington’s and Alzheimer’s diseases.

References
Yang, Y., Bedford, M.T. 2013. Nat Rev Cancer. 13(1):37-50.